Polarean has acquired the key assets and intellectual property for commercializing hyperpolarized gas MRI technology. By enabling leading academic institutions and industry scientists to freely pursue innovative ideas and applications we seek to unlock the extraordinary promise of this novel technology. Whether it’s basic physics, chemistry, or clinical imaging, our mission is to encourage adoption and exploration of hyperpolarized gas technology. We are committed to making this capability available in your lab and putting it under your control.
Location: United States, North Carolina, Durham
Employees: 1-10
Phone: +1 919-206-7900
Total raised: $3M
Founded date: 2011
Investors 2
| Date | Name | Website |
| - | Amphion In... | amphionplc... |
| - | Westlake V... | westlakeve... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.05.2019 | Grant | $3M | - |
Mentions in press and media 5
| Date | Title | Description |
| 20.06.2024 | Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives | DURHAM, NC and LONDON, June 20, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging (MRI) of the lungs, announces the closi... |
| 30.06.2023 | Recent Digital Health Hires & Board Appointments | Theralink Technologies, Inc. appoints Faith Zaslavsky as its new Chief Executive Officer. Ms. Zaslavsky, who has served as the Company’s President and Chief Operating Officer since December 2022, will assume this role effective June 26, 202... |
| 03.05.2023 | Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit | Durham, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc POLX, the medical imaging technology company, has been selected as one of the featured companies as a poster presenter at the American Thoracic Society's ("ATS") ... |
| 28.12.2022 | FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the Evaluation of Lung Ventilation | XENOVIEW represents the first and only hyperpolarized MRI contrast agent ● FDA approved indication includes both adolescents and adults representing a significant market opportunity /EIN News/ -- Durham, N.C., Dec. 28, 2022 (GLOBE NEWSWIRE)... |
| 30.09.2020 | POLAREAN IMAGING PLC Polarean Imaging : Interim Results for the six months ended 30 June 2020 | 30 September 2020 Polarean Imaging Plc ("Polarean" or the "Company") Half-year Report Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary investigational drug-device combination d... |